Recent Publications

  1. Zettlitz, K.A., Tavare, R., Tsai, W.K., Yamada, R.E., Ha, N.S., Collins, J., van Dam, R.M., Timmerman, J.M., & Wu, A.M. (2019). (18)F-labeled anti-human CD20 cys-diabody for same-day immunoPET in a model of aggressive B cell lymphoma in human CD20 transgenic mice. European Journal of Nuclear Medicine and Molecular Imaging, 46(2), 489-500.
  2. van Megen, K.M., van 't Wout, E.T., Lages Motta, J., Dekker, B., Nikolic, T., & Roep, B.O. (2019). Activated Mesenchymal Stromal Cells Process and Present Antigens Regulating Adaptive Immunity. Frontiers in Immunology, 10, 694.
  3. Aldoss, I., Capelletti, M., Park, J., Pistofidis, R.S., Pillai, R., Stiller, T., Sanchez, J.F., Forman, S.J., Ghobrial, I.M., & Krishnan, A. (2019). Acute lymphoblastic leukemia as a clonally unrelated second primary malignancy after multiple myeloma. Leukemia, 33, 266-70.
  4. Xiao, R., Mansour, A.G., Huang, W., Chrislip, L.A., Wilkins, R.K., Queen, N.J., Youssef, Y., Mao, H.C., Caligiuri, M.A., & Cao, L. (2019). Adipocytes: A Novel Target for IL-15/IL-15Rα Cancer Gene Therapy. Molecular Therapy, 27(5), 922-32.
  5. Li, Y.J., Du, L., Wang, J., Vega, R., Lee, T.D., Miao, Y., Aldana-Masangkay, G., Samuels, E.R., Li, B., Ouyang, S.X., Colayco, S.A., Bobkova, E.V., Divlianska, D.B., Sergienko, E., Chung, T.D.Y., Fakih, M., & Chen, Y. (2019). Allosteric Inhibition of Ubiquitin-like Modifications by a Class of Inhibitor of SUMO-Activating Enzyme. Cell Chemical Biology, 26(2), 278-88.e6.
  6. He, Y., Hooker, E., Yu, E.J., Cunha, G.R., Liao, L., Xu, J., Earl, A., Wu, H., Gonzalgo, M.L., & Sun, Z. (2019). Androgen signaling is essential for development of prostate cancer initiated from prostatic basal cells. Oncogene, 38(13), 2337-50.
  7. Roep, B.O., Wheeler, D.C.S., & Peakman, M. (2019). Antigen-based immune modulation therapy for type 1 diabetes: the era of precision medicine. Lancet Diabetes Endocrinol, 7(1), 65-74.
  8. Zhou, J., Li, H., Xia, X., Herrera, A., Pollock, N., Reebye, V., Sodergren, M.H., Dorman, S., Littman, B.H., Doogan, D., Huang, K.W., Habib, R., Blakey, D., Habib, N.A., & Rossi, J.J. (2019). Anti-inflammatory Activity of MTL-CEBPA, a Small Activating RNA Drug, in LPS-Stimulated Monocytes and Humanized Mice. Molecular Therapy, 27(5), 999-1016.
  9. Shinde, A., Li, R., Amini, A., & Glaser, S. (2019). Can Immunotherapy Replace Radiotherapy in Melanoma Brain Metastases? Journal of Clinical Oncology, 37(12), 1030-1.
  10. Pow-Anpongkul, P., Chu, P.G., & Kidambi, T.D. (2019). Capecitabine-Induced Enteritis Leading to Small Bowel Obstruction. Gastroenterology, 156(5), e8-e9.
  11. Brown, C.E., & Mackall, C.L. (2019). CAR T cell therapy: inroads to response and resistance. Nature Reviews Immunology, 19(2), 73-4.
  12. Song, J.Y., & Herrera, A.F. (2019). CAR T cells mimicking an aggressive lymphoma. Blood, 133(13), 1517.
  13. Fong, Y. (2019). Care After Liver Resection for Hepatocellular Carcinoma. JAMA Surg, ePub ahead of print.
  14. Shinde, A., & Amini, A. (2019). Challenging Current Conventions: Up-Front Stereotactic Radiosurgery Alone for Limited Brain Metastases in Small Cell Lung Cancer. International Journal of Radiation Oncology Biology Physics, 103(5), 1031-2.
  15. Pal, S.K., Miller, M.J., Agarwal, N., Chang, S.M., Chavez-MacGregor, M., Cohen, E., Cole, S., Dale, W., Magid Diefenbach, C.S., Disis, M.L., Dreicer, R., Graham, D.L., Henry, N.L., Jones, J., Keedy, V., Klepin, H.D., Markham, M.J., Mittendorf, E.A., Rodriguez-Galindo, C., Sabel, M.S., Schilsky, R.L., Sznol, M., Tap, W.D., Westin, S.N., & Johnson, B.E. (2019). Clinical Cancer Advances 2019: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology. Journal of Clinical Oncology, 37(10), 834-49.
  16. He, Z.Y., Li, M.F., Lin, J.H., Lin, D., & Lin, R.J. (2019). Comparing the efficacy of concurrent EGFR-TKI and whole-brain radiotherapy vs EGFR-TKI alone as a first-line therapy for advanced EGFR-mutated non-small-cell lung cancer with brain metastases: a retrospective cohort study. Cancer Management and Research, 11, 2129-38.
  17. Setten, R.L., Rossi, J.J., & Han, S.P. (2019). The current state and future directions of RNAi-based therapeutics. Nature Reviews: Drug Discovery, 18(6), 421-46.
  18. Hewelt, B., Li, H., Jolly, M.K., Kulkarni, P., Mambetsariev, I., & Salgia, R. (2019). The DNA Walk and its Demonstration of Deterministic Chaos- Relevance to Genomic Alterations in Lung Cancer. Bioinformatics, ePub ahead of print.
  19. Zhang, J., Oh, E., Merz, K.E., Aslamy, A., Veluthakal, R., Salunkhe, V.A., Ahn, M., Tunduguru, R., & Thurmond, D.C. (2019). DOC2B promotes insulin sensitivity in mice via a novel KLC1-dependent mechanism in skeletal muscle. Diabetologia, 62(5), 845-59.
  20. Salgia, N.J., & Pal, S.K. (2019). Editorial Comment. The Journal of urology, 201(3), 548.
  21. Kidambi, T.D., Terdiman, J.P., El-Nachef, N., Singh, A., Kattah, M.G., & Lee, J.K. (2019). Effect of I-scan Electronic Chromoendoscopy on Detection of Adenomas During Colonoscopy. Clinical Gastroenterology and Hepatology, 17(4), 701-8.e1.
  22. Querfeld, C. (2019). The emerging role of microRNAs in the molecular diagnosis of mycosis fungoides. British Journal of Dermatology, 180(5), 984-5.
  23. Kato, M., & Natarajan, R. (2019). Epigenetics and epigenomics in diabetic kidney disease and metabolic memory. Nat Rev Nephrol, 15(6), 327-45.
  24. van Lummel, M., Buis, D.T.P., Ringeling, C., de Ru, A.H., Pool, J., Papadopoulos, G.K., van Veelen, P.A., Reijonen, H., Drijfhout, J.W., & Roep, B.O. (2019). Epitope Stealing as a Mechanism of Dominant Protection by HLA-DQ6 in Type 1 Diabetes. Diabetes, 68(4), 787-95.
  25. Mortimer, J.E., & Shively, J.E. (2019). Functional Imaging of Human Epidermal Growth Factor Receptor 2-Positive Breast Cancers and a Note about NOTA. Journal of Nuclear Medicine, 60(1), 23-5.
  26. Rhodes, C.J., Batai, K., Bleda, M., Haimel, M., Southgate, L., Germain, M., Pauciulo, M.W., Hadinnapola, C., Aman, J., Girerd, B., Arora, A., Knight, J., Hanscombe, K.B., Karnes, J.H., Kaakinen, M., Gall, H., Ulrich, A., Harbaum, L., Cebola, I., Ferrer, J., Lutz, K., Swietlik, E.M., Ahmad, F., Amouyel, P., Archer, S.L., Argula, R., Austin, E.D., Badesch, D., Bakshi, S., Barnett, C., Benza, R., Bhatt, N., Bogaard, H.J., Burger, C.D., Chakinala, M., Church, C., Coghlan, J.G., Condliffe, R., Corris, P.A., Danesino, C., Debette, S., Elliott, C.G., Elwing, J., Eyries, M., Fortin, T., Franke, A., Frantz, R.P., Frost, A., Garcia, J.G.N., Ghio, S., Ghofrani, H.A., Gibbs, J.S.R., Harley, J., He, H., Hill, N.S., Hirsch, R., Houweling, A.C., Howard, L.S., Ivy, D., Kiely, D.G., Klinger, J., Kovacs, G., Lahm, T., Laudes, M., Machado, R.D., MacKenzie Ross, R.V., Marsolo, K., Martin, L.J., Moledina, S., Montani, D., Nathan, S.D., Newnham, M., Olschewski, A., Olschewski, H., Oudiz, R.J., Ouwehand, W.H., Peacock, A.J., Pepke-Zaba, J., Rehman, Z., Robbins, I., Roden, D.M., Rosenzweig, E.B., Saydain, G., Scelsi, L., Schilz, R., Seeger, W., Shaffer, C.M., Simms, R.W., Simon, M., Sitbon, O., Suntharalingam, J., Tang, H., Tchourbanov, A.Y., Thenappan, T., Torres, F., Toshner, M.R., Treacy, C.M., Vonk Noordegraaf, A., Waisfisz, Q., Walsworth, A.K., Walter, R.E., Wharton, J., White, R.J., Wilt, J., Wort, S.J., Yung, D., Lawrie, A., Humbert, M., Soubrier, F., Trégouët, D.A., Prokopenko, I., Kittles, R., Gräf, S., Nichols, W.C., Trembath, R.C., Desai, A.A., Morrell, N.W., Wilkins, M.R., Uk Nihr BioResource Rare Diseases Consortium, Uk Pah Cohort Study Consortium, & Us Pah Biobank Consortium. (2019). Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysis. The Lancet Respiratory Medicine, 7(3), 227-38.
  27. Heavican, T.B., Bouska, A., Yu, J., Lone, W., Amador, C., Gong, Q., Zhang, W., Li, Y., Dave, B.J., Nairismagi, M.L., Greiner, T.C., Vose, J., Weisenburger, D.D., Lachel, C., Wang, C., Fu, K., Stevens, J.M., Lim, S.T., Ong, C.K., Gascoyne, R.D., Missiaglia, E., Lemonnier, F., Haioun, C., Hartmann, S., Pedersen, M.B., Laginestra, M.A., Wilcox, R.A., Teh, B.T., Yoshida, N., Ohshima, K., Seto, M., Rosenwald, A., Ott, G., Campo, E., Rimsza, L.M., Jaffe, E.S., Braziel, R.M., d'Amore, F., Inghirami, G., Bertoni, F., de Leval, L., Gaulard, P., Staudt, L.M., McKeithan, T.W., Pileri, S., Chan, W.C., & Iqbal, J. (2019). Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma. Blood, 133(15), 1664-76.
  28. Dadwal, S.S. (2019). Herpes Virus Infections Other than Cytomegalovirus in the Recipients of Hematopoietic Stem Cell Transplantation. Infectious Disease Clinics of North America, 33(2), 467-84.
  29. Hinz, S., & LaBarge, M.A. (2019). Hijacking EMT: Better Fat Than Dead. Cancer Cell, 35(1), 1-2.
  30. Li, C., Dong, L., Su, R., Bi, Y., Qing, Y., Deng, X., Zhou, Y., Hu, C., Yu, M., Huang, H., Jiang, X., Li, X., He, X., Zou, D., Shen, C., Han, L., Sun, M., Skibbe, J., Ferchen, K., Qin, X., Weng, H., Huang, H., Song, C., Chen, J., & Jin, J. (2019). Homoharringtonine exhibits potent anti-tumor effect and modulates DNA epigenome in acute myeloid leukemia by targeting SP1/TET1/5hmC. Haematologica, ePub ahead of print.
  31. Mei, M., Aldoss, I., Marcucci, G., & Pullarkat, V. (2019). Hypomethylating agents in combination with venetoclax for acute myeloid leukemia: Update on clinical trial data and practical considerations for use. American Journal of Hematology, 94(3), 358-62.
  32. Yim, J.H., Choi, A.H., Li, A.X., Qin, H., Chang, S., Tong, S.T., Chu, P., Kim, B.W., Schmolze, D., Lew, R., Ibrahim, Y., Poroyko, V.A., Salvatierra, S., Baker, A., Wang, J., Wu, X., Pfeifer, G.P., Fong, Y., & Hahn, M.A. (2019). Identification of Tissue-Specific DNA Methylation Signatures for Thyroid Nodule Diagnostics. Clinical Cancer Research, 25(2), 544-51.
  33. Wang, Y., Zhang, Y., Yi, P., Dong, W., Nalin, A.P., Zhang, J., Zhu, Z., Chen, L., Benson, D.M., Mundy-Bosse, B.L., Freud, A.G., Caligiuri, M.A., & Yu, J. (2019). The IL-15-AKT-XBP1s signaling pathway contributes to effector functions and survival in human NK cells. Nature Immunology, 20, 10-7.
  34. Alizadeh, D., Wong, R.A., Yang, X., Wang, D., Pecoraro, J.R., Kuo, C.F., Aguilar, B., Qi, Y., Ann, D.K., Starr, R., Urak, R., Wang, X., Forman, S.J., & Brown, C.E. (2019). IL-15-mediated reduction of mTORC1 activity preserves the stem cell memory phenotype of CAR-T cells and confers superior antitumor activity. Cancer Immunol Res, 7(5), 759-72.
  35. Liu, S.B., Dong, H.J., Bao, X.B., Qiu, Q.C., Li, H.Z., Shen, H.J., Ding, Z.X., Wang, C., Chu, X.L., Yu, J.Q., Tao, T., Li, Z., Tang, X.W., Chen, S.N., Wu, D.P., Li, L., & Xue, S.L. (2019). Impact of FLT3-ITD length on prognosis of acute myeloid leukemia. Haematologica, 104(1), e9-e12.
  36. Chang, L., Shen, L., Zhou, H., Gao, J., Pan, H., Zheng, L., Armstrong, B., Peng, Y., Peng, G., Zhou, B.P., Rosen, S.T., & Shen, B. (2019). ITCH nuclear translocation and H1.2 polyubiquitination negatively regulate the DNA damage response. Nucleic Acids Research, 47(2), 824-42.
  37. Lin, M., Nebral, K., Gertzen, C.G.W., Ganmore, I., Haas, O.A., Bhatia, S., Fischer, U., Kuhlen, M., Gohlke, H., Izraeli, S., Trka, J., Hu, J., Borkhardt, A., Hauer, J., & Auer, F. (2019). JAK2 p.G571S in B-cell precursor acute lymphoblastic leukemia: a synergizing germline susceptibility. Leukemia, ePub ahead of print.
  38. Zhang, J.-Y., Zhang, P.-P., Zhou, W.-P., Yu, J.-Y., Yao, Z.-H., Chu, J.-F., Yao, S.-N., Wang, C., Lone, W., Xia, Q.-X., Ma, J., Yang, S.-J., Liu, K.-D., Dong, Z.-G., Guo, Y.-J., Smith, L.M., McKeithan, T.W., Chan, W.C., Iqbal, J., & Liu, Y.-Y. (2019). L-Type Cav 1.2 Calcium Channel-α-1C Regulates Response to Rituximab in Diffuse Large B-Cell Lymphoma. Clinical Cancer Research, ePub ahead of print.
  39. Muschen, M. (2019). Metabolic gatekeepers to safeguard against autoimmunity and oncogenic B cell transformation. Nature Reviews Immunology, 19(5), 337-48.
  40. Yin, S., Gambe, R.G., Sun, J., Martinez, A.Z., Cartun, Z.J., Regis, F.F.D., Wan, Y., Fan, J., Brooks, A.N., Herman, S.E.M., Ten Hacken, E., Taylor-Weiner, A., Rassenti, L.Z., Ghia, E.M., Kipps, T.J., Obeng, E.A., Cibulskis, C.L., Neuberg, D., Campagna, D.R., Fleming, M.D., Ebert, B.L., Wiestner, A., Leshchiner, I., DeCaprio, J.A., Getz, G., Reed, R., Carrasco, R.D., Wu, C.J., & Wang, L. (2019). A Murine Model of Chronic Lymphocytic Leukemia Based on B Cell-Restricted Expression of Sf3b1 Mutation and Atm Deletion. Cancer Cell, 35(2), 283-96 e5.
  41. Bian, C., Zhang, C., Luo, T., Vyas, A., Chen, S.H., Liu, C., Kassab, M.A., Yang, Y., Kong, M., & Yu, X. (2019). NADP(+) is an endogenous PARP inhibitor in DNA damage response and tumor suppression. Nat Commun, 10(1), Article number: 693.
  42. Shinde, A., Li, R., Glaser, S., & Amini, A. (2019). Node-positive Nonmetastatic Prostate Cancer: Time to Reconsider Prognostic Staging? European Urology, 75(3), 355-7.
  43. Xu, B., Ma, R., Russell, L., Yoo, J.Y., Han, J.F., Cui, H.W., Yi, P., Zhang, J.Y., Nakashima, H., Dai, H.S., Chiocca, E.A., Kaur, B., Caligiuri, M.A., & Yu, J.H. (2019). An oncolytic herpesvirus expressing E-cacherin improves survival in mouse models of glioblastoma. Nature Biotechnology, 37(1), 45-54.
  44. Armenian, S.H., & Ehrhardt, M.J. (2019). Optimizing Cardiovascular Care in Children With Acute Myeloid Leukemia to Improve Cancer-Related Outcomes. Journal of Clinical Oncology, 37(1), 1-6.
  45. Lowman, X.H., Hanse, E.A., Yang, Y., Ishak Gabra, M.B., Tran, T.Q., Li, H., & Kong, M. (2019). p53 Promotes Cancer Cell Adaptation to Glutamine Deprivation by Upregulating Slc7a3 to Increase Arginine Uptake. Cell Reports, 26(11), 3051-60.e4.
  46. Mortimer, J., Di Palma, J., Schmid, K., Ye, Y., & Jahanzeb, M. (2019). Patterns of occurrence and implications of neratinib-associated diarrhea in patients with HER2-positive breast cancer: Analyses from the randomized phase III ExteNET trial Breast Cancer Research, 21(1), 32.
  47. Bergerot, C.D., Bergerot, P.G., Philip, E.J., Hsu, J.A., Dizman, N., Vaishampayan, U., Dorff, T., & Pal, S.K. (2019). Perception of cure among patients with metastatic genitourinary cancer initiating immunotherapy. J Immunother Cancer, 7(1), 71.
  48. Pal, S.K., Forero-Torres, A., Thompson, J.A., Morris, J.C., Chhabra, S., Hoimes, C.J., Vogelzang, N.J., Boyd, T., Bergerot, P.G., Adashek, J.J., Li, H., Yu, X., Gartner, E.M., Carret, A.S., & Smith, D.C. (2019). A phase 1 trial of SGN-CD70A in patients with CD70-positive, metastatic renal cell carcinoma. Cancer, 125(7), 1124-32.
  49. Martin, T., Strickland, S., Glenn, M., Charpentier, E., Guillemin, H., Hsu, K., & Mikhael, J. (2019). Phase I trial of isatuximab monotherapy in the treatment of refractory multiple myeloma. Blood cancer journal, 9(4), 41.
  50. Mikhael, J., Richardson, P., Usmani, S.Z., Raje, N., Bensinger, W., Karanes, C., Campana, F., Kanagavel, D., Dubin, F., Liu, Q., Semiond, D., & Anderson, K. (2019). A Phase Ib study of isatuximab plus pomalidomide/dexamethasone in relapsed/refractory multiple myeloma. Blood, ePub ahead of print.
  51. Gong, J., Cho, M., Gupta, R., Synold, T.W., Frankel, P., Ruel, C., Fakih, M., Chung, V., Lim, D., & Chao, J. (2019). A Pilot Study of Vinorelbine Safety and Pharmacokinetics in Patients with Varying Degrees of Liver Dysfunction. Oncologist, ePub ahead of print.
  52. Armenian, S.H., Gibson, C.J., Rockne, R.C., & Ness, K.K. (2019). Premature Aging in Young Cancer Survivors. Journal of the National Cancer Institute, 111(3), 226-32.
  53. Shinde, A., Li, R., Amini, A., & Glaser, S. (2019). Re: Liselotte M.S. Boeve, Maarten C.C.M. Hulshof, Andre N. Vis, et al. Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial. Eur Urol 2019;75:410-8: Future Steps for Definitive Therapy in Metastatic Prostate Cancer: Lessons from the HORRAD Trial. European Urology, 75(3), e69-e70.
  54. Mohanty, A., Sandoval, N., Phan, A., Nguyen, T.V., Chen, R.W., Budde, E., Mei, M., Popplewell, L., Pham, L.V., Kwak, L.W., Weisenburger, D.D., Rosen, S.T., Chan, W.C., Muschen, M., & Ngo, V.N. (2019). Regulation of SOX11 expression through CCND1 and STAT3 in mantle cell lymphoma. Blood, 133(4), 306-18.
  55. Mbongue, J.C., Rawson, J., Garcia, P.A., Gonzalez, N., Cobb, J., Kandeel, F., Ferreri, K., & Husseiny, M.I. (2019). Reversal of New Onset Type 1 Diabetes by Oral Salmonella-Based Combination Therapy and Mediated by Regulatory T-Cells in NOD Mice. Frontiers in Immunology, 10, 320.
  56. Singhal, J., Chikara, S., Horne, D., Salgia, R., Awasthi, S., & Singhal, S.S. (2019). RLIP inhibition suppresses breast-to-lung metastasis. Cancer Letters, 447, 24-32.
  57. Singhal, S.S., Salgia, R., Singhal, S., Horne, D., & Awasthi, S. (2019). RLIP: An existential requirement for breast carcinogenesis. Biochimica et Biophysica Acta - Reviews on Cancer, 1871(2), 281-8.
  58. Yoon, S., Wu, X., Armstrong, B., Habib, N., & Rossi, J.J. (2019). An RNA Aptamer Targeting the Receptor Tyrosine Kinase PDGFRalpha Induces Anti-tumor Effects through STAT3 and p53 in Glioblastoma. Mol Ther Nucleic Acids, 14, 131-41.
  59. Jothishankar, B., Almazan, T., Kim, Y., Liauw, S., Smith, S., Kline, J., & Abdulla, F. (2019). Romidepsin and total skin electron beam therapy in advanced stage mycosis fungoides and Sézary syndrome. British Journal of Haematology, ePub ahead of print.
  60. Huang, Y., Su, R., Sheng, Y., Dong, L., Dong, Z., Xu, H., Ni, T., Zhang, Z.S., Zhang, T., Li, C., Han, L., Zhu, Z., Lian, F., Wei, J., Deng, Q., Wang, Y., Wunderlich, M., Gao, Z., Pan, G., Zhong, D., Zhou, H., Zhang, N., Gan, J., Jiang, H., Mulloy, J.C., Qian, Z., Chen, J., & Yang, C.G. (2019). Small-Molecule Targeting of Oncogenic FTO Demethylase in Acute Myeloid Leukemia. Cancer Cell, 35(4), 677-91.e10.
  61. Chen, S.H., & Yu, X. (2019). Targeting dePARylation selectively suppresses DNA repair-defective and PARP inhibitor-resistant malignancies. Sci Adv, 5(4), eaav4340.
  62. Roth, D., Chiang, A.J., Hu, W., Gugiu, G.B., Morra, C.N., Versalovic, J., & Kalkum, M. (2019). Two-carbon folate cycle of commensal Lactobacillus reuteri 6475 gives rise to immunomodulatory ethionine, a source for histone ethylation. FASEB Journal, 33(3), 3536-48.
  63. Chan, W.C. (2019). Using Gene Expression Profiling to Move Beyond MYC/BCL2 Rearrangements in High-Grade Lymphoma. Journal of Clinical Oncology, 37(3), 175-7.
  64. Tsou, T.C., Gowen, K., Ali, S.M., Miller, V.A., Schrock, A.B., Lovly, C.M., & Reckamp, K.L. (2019). Variable Response to ALK Inhibitors in NSCLC with a Novel MYT1L-ALK Fusion. Journal of Thoracic Oncology, 14(2), e29-e30.
  65. Haddad, R.I., Massarelli, E., Lee, J.J., Lin, H.Y., Hutcheson, K., Lewis, J., Garden, A.S., Blumenschein, G.R., William, W.N., Pharaon, R.R., Tishler, R.B., Glisson, B.S., Pickering, C., Gold, K.A., Johnson, F.M., Rabinowits, G., Ginsberg, L.E., Williams, M.D., Myers, J., Kies, M.S., & Papadimitrakopoulou, V. (2019). Weekly paclitaxel, carboplatin, cetuximab, and cetuximab, docetaxel, cisplatin, and fluorouracil, followed by local therapy in previously untreated, locally advanced head and neck squamous cell carcinoma. Annals of Oncology, 30(3), 471-7.
  66. Chlebowski, R.T., Luo, J.H., Anderson, G.L., Barrington, W., Reding, K., Simon, M.S., Manson, J.E., Rohan, T.E., Wactawski-Wende, J., Lane, D., Strickler, H., Mosaver-Rahmani, Y., Freudenheim, J.L., Saquib, N., & Stefanick, M.L. (2019). Weight loss and breast cancer incidence in postmenopausal women. Cancer, 125(2), 205-12.